암에 중요한 유전자 II: 종양 억제 유전자

Tumor suppressor genes encode proteins that inhibit cell proliferation and trigger cell apoptosis, either directly or indirectly. Under normal conditions, these genes slow down cell division, repair errors in DNA, or control programmed cell death. When tumor suppressor genes function properly, they maintain regulated cell cycle progression and prevent uncontrolled cell growth that could lead to cancer development.

Loss-of-function mutations in tumor suppressor genes act in a recessive manner, meaning both alleles must lose their function to cause uncontrolled cell proliferation. A mutation in a single allele does not necessarily affect the gene's overall function because the remaining functional allele can still produce protective proteins. Only when both copies are inactivated does the cell lose tumor suppression and begin proliferating uncontrollably.

Proto-oncogenes lead to cancer upon over-activation or gain-of-function mutations, while tumor suppressor genes cause cancer when they are inactivated or lose function. This fundamental difference means proto-oncogenes act dominantly to promote cancer, whereas tumor suppressor genes act recessively to prevent it. Understanding this distinction is essential for comprehending how cancer-critical genes contribute to malignant transformation.

Tumor suppressor genes like INK4, p53, and PTEN are very commonly mutated in many cancer types. The p53 gene inactivation has been identified in various human cancers, including leukemia and lymphoma. These frequently mutated genes represent critical control points in cell cycle regulation, making their loss particularly significant in cancer development.

When tumor suppressor gene function is disrupted, the cell cycle progression becomes unchecked and unregulated. Cells lose their ability to slow division, repair DNA errors, or undergo apoptosis when necessary. This disruption causes cells to proliferate uncontrollably and eventually develop into tumors as normal growth constraints are removed.

Most tumor suppressor gene mutations are acquired during a person's lifetime, though a few are inherited. Acquired mutations develop in somatic cells due to environmental factors or cellular errors, while inherited mutations are present from birth in germline cells. The predominance of acquired mutations explains why cancer typically develops later in life as these mutations accumulate.

Tumor suppressor gene mutations eliminate the cell's protective mechanisms that normally prevent excessive proliferation. Without functional tumor suppressors, cells cannot properly regulate their division cycle or respond to growth-inhibitory signals. This loss of control allows cells to bypass normal checkpoints and divide indefinitely, establishing the foundation for tumor formation and cancer progression.